Early Staged Consent Before Prostate Biopsy
Improving Patient Experience and Outcomes for Men Undergoing Prostate Biopsy: A Randomized Controlled Trial With Early Stage Consent
1 other identifier
interventional
390
1 country
1
Brief Summary
This is a study and a novel approach to clinical trials, testing the feasibility and acceptability of two-stage consent in the context of a trial integrated into routine clinical practice. The investigator will use, as a model, a trial of a brief mind-body intervention) with guided imagery for procedural pain at the time of prostate biopsy. In the two-stage design, patients will first be approached for consent to 1) have their routinely collected clinical data used for research purposes and 2) be randomly selected to be offered an intervention to improve the experience of prostate biopsy. Only patients randomized to the experimental arm will be informed about the benefits and harms of the intervention and will sign a second consent for the experimental treatment. There will be two separate randomizations in this study, one-stage (usual informed consent) vs. two-stage consent and mindfulness intervention vs. control.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable prostate-cancer
Started Apr 2018
Longer than P75 for not_applicable prostate-cancer
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 11, 2018
CompletedFirst Submitted
Initial submission to the registry
April 15, 2018
CompletedFirst Posted
Study publicly available on registry
April 25, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 14, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
October 14, 2024
CompletedOctober 16, 2024
October 1, 2024
6.5 years
April 15, 2018
October 15, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
number of patients who sign consent form
2 years
Study Arms (2)
Usual Care + Meditation
EXPERIMENTALUsual care (local anaesthesia) + audio-recorded brief mind-dody intervention for 10 minutes before and for 10 minutes during the prostate biopsy procedure
Usual Care Group
ACTIVE COMPARATORTime-and-attention control group receiving usual care (local anesthesia) including optional background music in the biopsy procedure room
Interventions
The brief mind-body intervention, specifically developed for this study, is a combination of "mindfulness meditation" with a specific cognitive component of "guided imagery". Patient intervention, they will be given headphones connected to an MP4 player in the clinic area to listen to a pre-biopsy mindfulness exercise (10 minutes). They will then be brought into the biopsy procedure room and given a second set of headphones, guiding the patient through the mindfulness intervention during the biopsy procedure (10 minutes).
Prostate needle biopsy under local anesthesia
Questionnaires completion will be by telephone interview or manual completion of paper or online REDCap instruments, depending on participant preference.
Eligibility Criteria
You may qualify if:
- All male patients that will be scheduled for standard prostate needle biopsy (first, repeat or active surveillance biopsy) under local anesthesia and potentially consented to the mindfulness study of mind-body intervention for prostate biopsy within the next 12 months.
- English fluent
You may not qualify if:
- Patient with prior rectal surgery or anal stricture requiring surgical intervention prior to biopsy.
- Prior prostate radiation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Memorial Sloan Kettering Cancer Center
New York, New York, 10065, United States
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Behrar Ehdaie, MD, MPH
Memorial Sloan Kettering Cancer Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 15, 2018
First Posted
April 25, 2018
Study Start
April 11, 2018
Primary Completion
October 14, 2024
Study Completion
October 14, 2024
Last Updated
October 16, 2024
Record last verified: 2024-10